Filing Flows › Comparisons › GKOS vs INSP
Glaukos vs Inspire Medical Systems: GKOS and INSP compared
Glaukos is the larger company: $211M of revenue in its latest quarter (Q3 2026) against $207M for Inspire Medical Systems (Q3 2026). Glaukos is growing faster (+58% against -8% a year earlier). Glaukos is more profitable, with an operating margin of 0.4% against -13.9%.
Where the money goes: GKOS and INSP
Glaukos (GKOS) · Q3 2026
Glaukos, Q3 2026: revenue $211M (+58% year over year), operating margin 0.4%, net earnings $2.0M, operating cash flow $38.6M. The chart follows the revenue to costs, profit and cash.
Inspire Medical Systems (INSP) · Q3 2026
Inspire Medical Systems, Q3 2026: revenue $207M (-8% year over year), operating margin -13.9%, net loss $24.4M, operating cash flow $46.4M. The chart follows the revenue to costs, profit and cash.
| Glaukos (GKOS) | Inspire Medical Systems (INSP) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $211M | $207M |
| Revenue growth, Y/Y | +58% | -8% |
| Gross margin | 85.2% | — |
| Operating margin | 0.4% | -13.9% |
| Net earnings | $2.0M | −$24.4M |
| Net margin | 1.0% | -11.8% |
| Operating cash flow | $38.6M | $46.4M |
| Free cash flow | $36.5M | $38.9M |
| Market value | $11.1B | $2.0B |
| P/E | — | 20.6× |
| Analysts’ mean target | $242.46 | $69.62 |
Where the revenue comes from
Glaukos
- Glaucoma: $152M (72%)
- Corneal Health: $59.0M (28%)
Questions
Which is bigger, Glaukos or Inspire Medical Systems?
Glaukos is the larger company: $211M of revenue in its latest quarter (Q3 2026) against $207M for Inspire Medical Systems (Q3 2026).
Is Glaukos or Inspire Medical Systems growing faster?
Glaukos is growing faster (+58% against -8% a year earlier).
Which is more profitable, Glaukos or Inspire Medical Systems?
Glaukos is more profitable, with an operating margin of 0.4% against -13.9%.
More: Glaukos earnings · how Glaukos makes money · Inspire Medical Systems earnings · how Inspire Medical Systems makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Oct 28, 2026; 10-Q filed Nov 2, 2026). Fiscal quarters can end on different dates. Not investment advice.